Kaken Pharmaceutical Co (TSE:4521) Effective Interest Rate on Debt % : 0.52% (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Kaken Pharmaceutical Co's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was 円20 Mil. Kaken Pharmaceutical Co's average total debt for the quarter that ended in Dec. 2023 was 円3,850 Mil. Therefore, Kaken Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 0.52%.

Kaken Pharmaceutical Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Kaken Pharmaceutical Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Effective Interest Rate on Debt % Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

0.44

Kaken Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															0.42	0.52	0.42	0.42	0.52

Competitive Comparison of Kaken Pharmaceutical Co's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaken Pharmaceutical Co's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Effective Interest Rate on Debt % falls into.

Kaken Pharmaceutical Co Effective Interest Rate on Debt % Calculation

Kaken Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Mar. 2022 )	+	Total Debt (A: Mar. 2023 ))	/ count )
=	-1 * -17	/	( (3850	+	3850)	/ 2 )
=	-1 * -17	/	3850
=	0.44 %

where

	Total Debt (A: Mar. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	3850
=	3850

	Total Debt (A: Mar. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	3850
=	3850

Kaken Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Sep. 2023 )	+	Total Debt (Q: Dec. 2023 ))	/ count )
=	-1 * -20	/	( (3850	+	3850)	/ 2 )
=	-1 * -20	/	3850
=	0.52 %

where

	Total Debt (Q: Sep. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	3850
=	3850

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	3850
=	3850

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Kaken Pharmaceutical Co (TSE:4521) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Kaken Pharmaceutical Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines